Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7955497 | 1.00 | NT5E (0.41) | NT5EHTTMAPTTYMPDRD2 | |
| SCHEMBL7957675 | 0.93 | NT5E (0.50) | NT5EHTTMAPT | |
| SCHEMBL7957672 | 0.93 | NT5E (0.50) | NT5EHTTMAPT | |
| SCHEMBL7957980 | 0.91 | NT5E (0.52) | NT5EHTTMAPT | |
| SCHEMBL7957983 | 0.91 | NT5E (0.52) | NT5EHTTMAPT | |
| SCHEMBL7957807 | 0.87 | TYMP (0.38) | NT5ETYMPALDH1A1 | |
| SCHEMBL7957974 | 0.87 | ALDH1A1 (0.41) | NT5EHTTMAPTTYMPALDH1A1 | |
| SCHEMBL8131545 | 0.84 | NT5E (0.43) | NT5EALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL7957682 | 0.84 | NT5E (0.54) | NT5EHTTMAPT | |
| SCHEMBL8131550 | 0.84 | NT5E (0.43) | NT5EALDH1A1LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6271342-B1 | SERUM STABILITY; FOR TUMOR THERAPY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-07 | — | — | US | disclosed |
| EP-0819135-B1 | SUGAR-MODIFIED CYTOSTATICS | BAYER AG (DE) | 1999-11-17 | — | — | EP | disclosed |